genomic sequencing
Mayo Clinic researchers are studying the cost-effectiveness of genomic research to detect certain diseases earlier, including breast, ovarian and colorectal cancer.
Mayo Clinic announced an agreement on Tuesday, Oct. 12 that will allow it to offer clinical-grade comprehensive cancer genomic sequencing to cancer patients who choose to participate.